Deciphering the contribution of lipid droplets in leprosy: Multifunctional organelles with roles in Mycobacterium leprae pathogenesis

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue SUPPL.1, 2012, Pages 156-166

  de Mattos, Katherine Antunes ^a   Sarno, Euzenir Nunes ^a   Pessolani, Maria Cristina Vidal ^a   Bozza, Patricia T ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Bacterial survival; Eicosanoids; Inflammation; Leprosy; Lipid droplet; Nutritional source; Pathogenicity

Indexed keywords

LIPID;

ARTICLE; CELL INCLUSION; CELL ORGANELLE; HUMAN; IMMUNOLOGY; LEPROMATOUS LEPROSY; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM LEPRAE; PATHOLOGY; SCHWANN CELL;

HUMANS; INCLUSION BODIES; LEPROSY, LEPROMATOUS; LIPIDS; MYCOBACTERIUM LEPRAE; ORGANELLES; SCHWANN CELLS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM LEPRAE;

EID: 84871508519     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000900023     Document Type: Article

References (72)

1. Accioly MT, Pacheco P, Maya-Monteiro CM, Carrossini N, Robbs BK, Oliveira SS, Kaufmann C, Morgado-Diaz JA, Bozza PT, Viola JP 2008. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res 68: 1732-1740.
2. Alcais A, Mira M, Casanova J-L, Schurr E, Abel L 2005. Genetic dissection of immunity in leprosy. Curr Opin Immunol 17: 44-48.
3. Almeida PE, Silva AR, Maya-Monteiro CM, Töröcsik D, D'Avila H, Dezsö B, Magalhães KG, Castro-Faria-Neto HC, Nagy L, Bozza PT 2009. Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor-expression and activation: functions in inflammation, lipid metabolism and pathogenesis. J Immunol 183: 1337-1345.
4. Alvarez S, Blanco A, Fresno M, Munõz-Fernández MA 2010. Nuclear factor-kappaB activation regulates cyclooxygenase-2 induction in human astrocytes in response to CXCL12: role in neuronal toxicity. J Neurochem 113: 772-783.
5. Assunção-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, Souza DG, Pacheco P, Barbosa-Lima G, Gomes RN, Bozza PT, Da Poian AT, Teixeira MM, Bozza MT 2010. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J 24: 218-228.
6. Beil WJ, Weller PF, Peppercorn MA, Galli SJ, Dvorak AM 1995. Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol 58: 284-298.
7. Betz M, Fox BS 1991. Prostaglandin E2 inhibits production of Th1 lymphokines, but not of Th2 lymphokines. J Immunol 146: 108-113.
8. Boulant S, Targett-Adams P, McLauchlan J 2007. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J Gen Virol 88: 2204-2213.
9. Bozza PT, Bakker-Abreu I, Navarro-Xavier RA, Bandeira-Melo C 2011. Lipid body function in eicosanoid synthesis: an update. Prostaglandins Leukot Essent Fatty Acids 85: 205-213.
10. Bozza PT, D'Avila H, Almeida PE, Magalhães KG, Molinaro R, Almeida CJ, Maya-Monteiro CM 2009a. Lipid droplets in host-pathogen interactions. Clinical lipidology 4: 791-807.
11. Bozza PT, Magalhães KG, Weller PF 2009b. Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim Biophys Acta 1791: 540-551.
12. Bozza PT, Yu W, Cassara J, Weller PF 1998. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J Leukoc Biol 64: 563-569.
13. Cáceres N, Tapia G, Ojanguren I, Altare F, Gil O, Pinto S, Vilaplana C, Cardona PJ 2009. Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models. Tuberculosis 89: 175-182.
14. Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI 2007. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 75: 753-759.
15. Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO 2011. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity and disease outcome. Future Microbiol 6: 533-549.
16. Chatterjee KR, Das Gupta NN, De ML 1959. Electron microscopic observations on the morphology of Mycobacterium leprae. Exp Cell Res 18: 521-527.
17. Chen M, Divangahi M, Gan H, Shin DS, Hong S, Lee DM, Serhan CN, Behar SM, Remold HG 2008. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med Nov 205: 2791-2801.
18. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honoré N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG 2001. Massive gene decay in the leprosy bacillus. Nature 409: 1007-1011.
19. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 9: 1089-1097.
20. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling PA, Gutierrez MA, Navab M, Reddy ST, Witztum JL, Fogelman AM, Rea TH, Eisenberg D, Berliner J, Modlin RL 2008. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest 118: 2917-2928.
21. D'Avila H, Freire-de-Lima CG, Roque NR, Teixeira L, Barja-Fidalgo C, Silva AR, Melo RC, dos Reis GA, Castro Faria Neto HC, Bozza PT 2011. Host cell lipid bodies triggered by Trypanosoma cruzi infection and enhanced by the uptake of apoptotic cells are associated with PGE2 generation and increased parasite growth. J Infect Dis 204: 951-961.
22. D'Avila H, Maya-Monteiro CM, Bozza PT 2008a. Lipid bodies in innate immune response to bacterial and parasite infections. Int Immunopharmacol 8: 1308-1315.
23. D'Avila H, Melo RCN, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT 2006. Mycobacterium bovis bacillus Calmette-Guérin induces TLR2-mediated formation of LBs: intracellular domains for eicosanoid synthesis in vivo. J Immunol 176: 3087-3097.
24. D'Avila H, Roque NR, Cardoso RM, Castro-Faria-Neto HC, Melo RC, Bozza PT 2008b. Neutrophils recruited to the site of Mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell Microbiol 10: 2589-2604.
25. Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE 2011. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog 7 (Suppl.): S1-S16.
26. de Messias-Reason I, Kremsner PG, Kun JF 2009. Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis 199: 801-804.
27. Dooper MM, Wassink L, M'Rabet L, Graus YM 2002. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology 107: 152-159.
28. Dvorak AM, Morgan ES, Weller PF 2001. Ultrastructural immunolocalization of basic fibroblast growth factor to lipid bodies and secretory granules in human mast cells. Histochem J 33: 397-402.
29. Franzblau SG 1988. Oxidation of palmitic acid by Mycobacterium leprae in an axenic medium. J Clin Microbiol 26: 18-21.
30. Halvorsen B, Wæhre T, Scholz H, Clausen OP, von der Thüsen JH, Müller F, Heimli H, Tonstad S, Hall C, Frøland SS, Biessen EA, Damås JK, Aukrust P 2005. Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res 46: 211-219.
31. Job CK 1970. Mycobacterium leprae in nerve lesions in lepromatous leprosy: an electron microscopic study. Arch Pathol 89: 195-207.
32. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR 2005. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by Toll-like receptor agonists. Arterioscler Thromb Vasc Biol 25: 1220-1224.
33. Kim MJ, Wainwright HC, Locketz M, Bekker LG, Walther GB, Dittrich C, Visser A, Wang W, Hsu FF, Wiehart U, Tsenova L, Kaplan G, Russell DG 2010. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2: 258-274.
34. Kiszewski AE, Becerril E, Baquera J, Ruiz-Maldonado R, Hernández Pando R 2003. Expression of cyclooxygenase type 2 in lepromatous and tuberculoid leprosy lesions. Br J Dermatol 148: 795-798.
35. Krutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, Legaspi A, Liu PT, Cole ST, Godowski PJ, Maeda Y, Sarno EN, Norgard MV, Brennan PJ, Akira S, Rea TH, Modlin RL 2003. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 9: 525-532.
36. Kurup G, Mahadevan PR 1982. Cholesterol metabolism of macrophages in relation to the presence of Mycobacterium leprae. J Biosci 4: 307-316.
37. Lim KG, Wan HC, Bozza PT, Resnick MB, Wong DT, Cruikshank WW, Kornfeld H, Center DM, Weller PF 1996. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 156: 2566-2570.
38. Luo M, Fadeev EA, Groves JT 2005. Mycobactin-mediated iron acquisition within macrophages. Nat Chem Biol 1: 149-153.
39. Marques MA, Neves-Ferreira AG, da Silveira EK, Valente RH, Chapeaurouge A, Perales J, da Silva BR, Dobos KM, Spencer JS, Brennan PJ, Pessolani MC 2008. Deciphering the proteomic profile of Mycobacterium leprae cell envelope. Proteomics 8: 2477-2491.
40. Mattos KA, D'Avila H, Rodrigues LS, Oliveira VG, Sarno EN, Atella GC, Pereira GM, Bozza PT, Pessolani MC 2010. Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J Leukoc Biol 87: 371-384.
41. Mattos KA, Lara FA, Oliveira VG, Rodrigues LS, D'Avila H, Melo RC, Manso PP, Sarno EN, Bozza PT, Pessolani MC 2011a. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell Microbiol 13: 259-273.
42. Mattos KA, Oliveira VG, D'Avila H, Rodrigues LS, Pinheiro RO, Sarno EN, Pessolani MC, Bozza PT 2011b. TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence. J Immunol 187: 2548-2558.
43. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163: 3920-3927.
44. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9: 1089-1097.
45. Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, Chun R, Schenk M, Zhang X, Ferguson BG, Burdick AE, Sarno EN, Rea TH, Hewison M, Adams JS, Cheng G, Modlin RL 2009. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6: 343-353.
46. Moreno C, Rees AJ 1993. Striking the right balance; the role of cytokines in mycobacterial disease. Clin Exp Immunol 94: 1-3.
47. Moreno JR, Garcia IE, Hernandez MLG, Leon DA, Marquez R, Pando RH 2002. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106: 257-266.
48. Oliveira RB, Ochoa MT, Sieling PA, Rea TH, Rambukkana A, Sarno EN, Modlin RL 2003. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect Immun 71: 1427-1433.
49. Pacheco P, Bozza FA, Gomes RN, Bozza M, Weller PF, Castro-Faria-Neto HC, Bozza PT 2002. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular loci involved in eicosanoid metabolism. J Immunol 169: 6498-6506.
50. Pacheco P, Vieira-de-Abreu A, Gomes RN, Barbosa-Lima G, Wermelinger LB, Maya-Monteiro CM, Silva AR, Bozza MT, Castro-Faria-Neto HC, Bandeira-Melo C, Bozza PT 2007. Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response. J Immunol 179: 8500-8508.
51. Parkash O 2009. Classification of leprosy into multibacillary and paucibacillary groups: an analysis. FEMS Immunol Med Microbiol 55: 1-5.
52. Persson J, Nilsson J, Lindholm MW 2008. Interleukin-1β and tumor necrosis factor-α impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol 25: 70.
53. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffé M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, Altare F 2008. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4: e1000204.
54. Renz, H, Gong JH, Schmidt A, Nain M, Gemsa D 1988. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 141: 2388-2393.
55. Ridley DS 1974. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ 51: 451-465.
56. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 10: 943-948.
57. Saka HA, Valdivia RH 2012. Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu Rev Cell Dev Biol: 411-437.
58. Sakurai I, Skinsnes OK 1970. Lipids in leprosy 2. Histochemistry of lipids in human leprosy. Int J Lepr Other Mycobact Dis 38: 389-403.
59. Samsa MM, Mondotte JA, Iglesias NG, Assunção-Miranda I, Barbosa-Lima G, da Poian AT, Bozza PT, Gamarnik AV 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog 5: e1000632.
60. Schmid B, Rippmann JF, Tadayyon M, Hamilton BS 2005. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem Biophys Res Commun 328: 1073-1082.
61. Stewart CR, Stuart LM, Wilkinson K, van Gils J M, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161.
62. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10-14.
63. Tanigawa K, Suzuki K, Nakamura K, Akama T, Kawashima A, Wu H, Hayashi M, Takahashi S, Ikuyama S, Ito T, Ishii N 2008. Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol Lett 289: 72-79.
64. van der Meer-Janssen YP, van Galen J, Batenburg JJ, Helms JB 2010. Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome. Prog Lipid Res 49: 1-26.
65. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775-779.
66. Virchow R 1863. Die krankhaften Geschwu lste, August Hirschwald, Berlin, 208 pp.
67. Weissmann G 1993. Prostaglandins as modulators rather than mediators of inflammation. J Lipid Mediat 6: 275-286.
68. Wheeler PR 1989. Biosynthetic pathways in Mycobacterium leprae. Acta Leprol 7: 21-24.
69. Wheeler PR 2003. Leprosy - clues about the biochemistry of Mycobacterium leprae and its host-dependency from the genome. World J Microbiol Biotechnol 19: 1-16.
70. WHO - World Health Organization. 2010. Leprosy today. Available from: who.int/lep/en/.
71. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277-279.
72. Zehmer JK, Huang Y, Peng G, Pu J, Anderson RGW, Liu P 2009. A role for lipid droplets in inter-membrane lipid traffic. Proteomics 9: 914-921.